NCT01238159View on ClinicalTrials.gov

Concomitant Chemo-radiotherapy Followed by MIDLE Chemotherapy in Stage I/II Extranodal NK/T-cell Lymphoma

PHASE2CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

August 31, 2010

Primary Completion Date

December 31, 2014

Study Completion Date

December 31, 2014

Conditions
Extranodal NK-T-Cell Lymphoma, Nasal and Nasal-Type
Interventions
RADIATION

CCRT+MIDLE chemotherapy

Patients are planned to be treated with CCRT plus MIDLE chemotherapy

Trial Locations (1)

135710

Samsung Medical Center, Seoul

Sponsors

Collaborators (1)

Asan Medical Center
All Listed Sponsors
collaborator

Asan Medical Center

OTHER

collaborator

Yonsei University

OTHER

collaborator

Seoul National University

OTHER

collaborator

Chonnam National University

OTHER

lead

Samsung Medical Center

OTHER